These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 26027599)

  • 1. [Diagnosis and therapy for neurocognitive disorders in Parkinson's disease].
    Lucza T; Karádi K; Komoly S; Janszky J; Kállai J; Makkos A; Kovács M; Weintraut R; Deli G; Aschermann Z; Kovács N
    Orv Hetil; 2015 Jun; 156(23):915-26. PubMed ID: 26027599
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Screening Mild and Major Neurocognitive Disorders in Parkinson's Disease.
    Lucza T; Karádi K; Kállai J; Weintraut R; Janszky J; Makkos A; Komoly S; Kovács N
    Behav Neurol; 2015; 2015():983606. PubMed ID: 26078489
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic utility of Montreal Cognitive Assessment in the Fifth Edition of Diagnostic and Statistical Manual of Mental Disorders: major and mild neurocognitive disorders.
    Liew TM; Feng L; Gao Q; Ng TP; Yap P
    J Am Med Dir Assoc; 2015 Feb; 16(2):144-8. PubMed ID: 25282632
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sensitivity and specificity of Addenbrooke's Cognitive Examination, Mattis Dementia Rating Scale, Frontal Assessment Battery and Mini Mental State Examination for diagnosing dementia in Parkinson's disease.
    Kaszás B; Kovács N; Balás I; Kállai J; Aschermann Z; Kerekes Z; Komoly S; Nagy F; Janszky J; Lucza T; Karádi K
    Parkinsonism Relat Disord; 2012 Jun; 18(5):553-6. PubMed ID: 22405839
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An assessment of Movement Disorder Society Task Force diagnostic criteria for mild cognitive impairment in Parkinson's disease.
    Uysal-Cantürk P; Hanağası HA; Bilgiç B; Gürvit H; Emre M
    Eur J Neurol; 2018 Jan; 25(1):148-153. PubMed ID: 28941002
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparing Sensitivity and Specificity of Addenbrooke's Cognitive Examination-I, III and Mini-Addenbrooke's Cognitive Examination in Parkinson's Disease.
    Lucza T; Ascherman Z; Kovács M; Makkos A; Harmat M; Juhász A; Janszky J; Komoly S; Kovács N; Dorn K; Karádi K
    Behav Neurol; 2018; 2018():5932028. PubMed ID: 30369997
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Addenbrooke's Cognitive Examination validation in Parkinson's disease.
    Reyes MA; Perez-Lloret S; Roldan Gerschcovich E; Martin ME; Leiguarda R; Merello M
    Eur J Neurol; 2009 Jan; 16(1):142-7. PubMed ID: 19049504
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Screening of cognitive impairment in patients with Parkinson's disease: diagnostic validity of the Brazilian versions of the Montreal Cognitive Assessment and the Addenbrooke's Cognitive Examination-Revised.
    Sobreira E; Pena-Pereira MA; Eckeli AL; Sobreira-Neto MA; Chagas MH; Foss MP; Cholerton B; Zabetian CP; Mata IF; Tumas V
    Arq Neuropsiquiatr; 2015 Nov; 73(11):929-33. PubMed ID: 26517216
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cognitive screening in Parkinson's disease: Comparison of the Parkinson Neuropsychometric Dementia Assessment (PANDA) with 3 other short scales.
    Gasser AI; Calabrese P; Kalbe E; Kessler J; Rossier P
    Rev Neurol (Paris); 2016 Feb; 172(2):138-45. PubMed ID: 26494570
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cognitive impairment in early-stage non-demented Parkinson's disease patients.
    Pfeiffer HC; Løkkegaard A; Zoetmulder M; Friberg L; Werdelin L
    Acta Neurol Scand; 2014 May; 129(5):307-18. PubMed ID: 24117192
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New DSM-V neurocognitive disorders criteria and their impact on diagnostic classifications of mild cognitive impairment and dementia in a memory clinic setting.
    Tay L; Lim WS; Chan M; Ali N; Mahanum S; Chew P; Lim J; Chong MS
    Am J Geriatr Psychiatry; 2015 Aug; 23(8):768-79. PubMed ID: 25728011
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative sensitivity of the MoCA and Mattis Dementia Rating Scale-2 in Parkinson's disease.
    Hendershott TR; Zhu D; Llanes S; Zabetian CP; Quinn J; Edwards KL; Leverenz JB; Montine T; Cholerton B; Poston KL
    Mov Disord; 2019 Feb; 34(2):285-291. PubMed ID: 30776152
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Parkinson's disease-cognitive rating scale: psychometrics for mild cognitive impairment.
    Fernández de Bobadilla R; Pagonabarraga J; Martínez-Horta S; Pascual-Sedano B; Campolongo A; Kulisevsky J
    Mov Disord; 2013 Sep; 28(10):1376-83. PubMed ID: 23873810
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The new DSM-5 diagnosis of mild neurocognitive disorder and its relation to research in mild cognitive impairment.
    Sachs-Ericsson N; Blazer DG
    Aging Ment Health; 2015 Jan; 19(1):2-12. PubMed ID: 24914889
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Validation of the Hungarian version of Alzheimer's Disease Assessment Scale-Cognitive Subscale (ADAS-Cog) in patients with mild cognitive impairment].
    Papp E; Pákáski M; Drótos G; Kálmán J
    Psychiatr Hung; 2012; 27(6):426-34. PubMed ID: 23429337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Addenbrooke's cognitive examination III: diagnostic utility for detecting mild cognitive impairment and dementia in Parkinson's disease.
    Sousa NMF; Brucki SMD
    Arq Neuropsiquiatr; 2023 Feb; 81(2):155-163. PubMed ID: 36863401
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Staging of cognitive impairment in Parkinson's disease: validity of Quick Dementia Rating System.
    Mahmoudi Asl A; Mehdizadeh M; Raeesi Roudbari P; Mehdizadeh H; Habibi SA; Niazi Khatoon J; Taghizadeh G
    Disabil Rehabil; 2022 Jan; 44(1):44-51. PubMed ID: 32374182
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validation of the Spanish version of Addenbrooke's Cognitive Examination III for diagnosing dementia.
    Matias-Guiu JA; Fernández de Bobadilla R; Escudero G; Pérez-Pérez J; Cortés A; Morenas-Rodríguez E; Valles-Salgado M; Moreno-Ramos T; Kulisevsky J; Matías-Guiu J
    Neurologia; 2015; 30(9):545-51. PubMed ID: 25002342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical validity of the Mattis Dementia Rating Scale in differentiating mild cognitive impairment in Parkinson's disease and normative data.
    Bezdicek O; Michalec J; Nikolai T; Havránková P; Roth J; Jech R; Růžička E
    Dement Geriatr Cogn Disord; 2015; 39(5-6):303-11. PubMed ID: 25792240
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence Rates of Dementia and Mild Cognitive Impairment Are Affected by the Diagnostic Parameter Changes for Neurocognitive Disorders in the DSM-5 in a Korean Population.
    Han JW; So Y; Kim TH; Lee DY; Ryu SH; Kim SY; Kim SG; Kim SK; Youn JC; Jhoo JH; Kim JL; Lee SB; Lee JJ; Kwak KP; Moon SW; Kim BJ; Bae JN; Woo JI; Jeong H; Park JH; Kim YJ; Kim KW
    Dement Geriatr Cogn Disord; 2017; 43(3-4):193-203. PubMed ID: 28237992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.